These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 7818564)

  • 41. [Usefulness of thiopurine methyltransferase polymorphism study and metabolites measurement for patients treated by azathioprine].
    Guillotin V; Galli G; Viallard JF
    Rev Med Interne; 2018 Jun; 39(6):421-426. PubMed ID: 29370945
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Mistaken identity: misclassification of TPMT phenotype following blood transfusion.
    Cheung ST; Allan RN
    Eur J Gastroenterol Hepatol; 2003 Nov; 15(11):1245-7. PubMed ID: 14560161
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Fatal myelotoxicity after azathioprine treatment.
    Slanar O; Chalupná P; Novotný A; Bortlík M; Krska Z; Lukás M
    Nucleosides Nucleotides Nucleic Acids; 2008 Jun; 27(6):661-5. PubMed ID: 18600523
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Toxic effects of azathioprine in rheumatoid arthritis. A national post-marketing perspective.
    Singh G; Fries JF; Spitz P; Williams CA
    Arthritis Rheum; 1989 Jul; 32(7):837-43. PubMed ID: 2751718
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Enzyme activities of purine catabolism and salvage in human muscle tissue.
    Schopf G; Havel M; Fasol R; Müller MM
    Adv Exp Med Biol; 1986; 195 Pt B():507-9. PubMed ID: 3020923
    [No Abstract]   [Full Text] [Related]  

  • 46. Two cases of thiopurine methyltransferase (TPMT) deficiency--a lucky save and a near miss with azathioprine.
    Gardiner SJ; Gearry RB; Barclay ML; Begg EJ
    Br J Clin Pharmacol; 2006 Oct; 62(4):473-6. PubMed ID: 16995868
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A case of azathioprine-induced aplastic anemia.
    Montgomery HD; Agarwal AM; Lim MY
    Int J Lab Hematol; 2022 Dec; 44(6):1015-1016. PubMed ID: 35799500
    [TBL] [Abstract][Full Text] [Related]  

  • 48. TPMT testing before azathioprine therapy?
    Drug Ther Bull; 2009 Jan; 47(1):9-12. PubMed ID: 19129430
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Monitoring of azathioprine-induced immunosuppression with thiopurine methyltransferase activity in kidney transplant recipients.
    Mircheva J; Legendre C; Soria-Royer C; Thervet E; Beaune P; Kreis H
    Transplantation; 1995 Oct; 60(7):639-42. PubMed ID: 7570968
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Thiopurine methyltransferase gene polymorphisms in Chinese patients with inflammatory bowel disease.
    Cao Q; Zhu Q; Shang Y; Gao M; Si J
    Digestion; 2009; 79(1):58-63. PubMed ID: 19252404
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Severe azathioprine-induced myelotoxicity in a kidney transplant patient with thiopurine S-methyltransferase-deficient genotype (TPMT*3A/*3C).
    Kurzawski M; Dziewanowski K; Ciechanowski K; Droździk M
    Transpl Int; 2005 May; 18(5):623-5. PubMed ID: 15819814
    [No Abstract]   [Full Text] [Related]  

  • 52. Relationship between the levels of purine salvage pathway enzymes and clinical/biological aggressiveness of human colon carcinoma.
    Sanfilippo O; Camici M; Tozzi MG; Turriani M; Faranda A; Ipata PL; Silvestrini R
    Cancer Biochem Biophys; 1994 Apr; 14(1):57-66. PubMed ID: 7796389
    [TBL] [Abstract][Full Text] [Related]  

  • 53. ITPA Activity in Adults and Children Treated With or Without Azathioprine: Relationship Between TPMT Activity, Thiopurine Metabolites, and Co-medications.
    Citterio-Quentin A; Moulsma M; Gustin MP; Boulieu R
    Ther Drug Monit; 2017 Oct; 39(5):483-491. PubMed ID: 28650902
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Azathioprine-induced fatal myelosuppression in systemic lupus erythematosus patient carrying TPMT*3C polymorphism.
    Boonsrirat U; Angsuthum S; Vannaprasaht S; Kongpunvijit J; Hirankarn N; Tassaneeyakul W; Avihingsanon Y
    Lupus; 2008 Feb; 17(2):132-4. PubMed ID: 18250137
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Azathioprine and 6-mercaptopurine pharmacogenetics and metabolite monitoring in inflammatory bowel disease.
    Gearry RB; Barclay ML
    J Gastroenterol Hepatol; 2005 Aug; 20(8):1149-57. PubMed ID: 16048561
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Thiopurine methyltransferase: should it be measured before commencing thiopurine drug therapy?
    Sanderson J; Ansari A; Marinaki T; Duley J
    Ann Clin Biochem; 2004 Jul; 41(Pt 4):294-302. PubMed ID: 15298741
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Normal thiopurine methyltransferase phenotype testing in a Crohn disease patient with azathioprine induced myelosuppression.
    Leung M; Piatkov I; Rochester C; Boyages SC; Leong RW
    Intern Med J; 2009 Feb; 39(2):121-6. PubMed ID: 19356188
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Azathioprine treatment and thiopurine metabolism in rheumatic diseases. Introduction and first results of investigation.
    Stolk JN; Boerbooms AM; De Abreu RA; van de Putte LB
    Adv Exp Med Biol; 1998; 431():487-93. PubMed ID: 9598116
    [No Abstract]   [Full Text] [Related]  

  • 59. Outcome of patients on azathioprine: a need for a better pre-treatment assessment and dosing guideline.
    Jabin D; Kumar S; Gow PJ
    N Z Med J; 2010 Oct; 123(1324):67-73. PubMed ID: 20953224
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Purine metabolism in cultured human fibroblasts derived from patients deficient in hypoxanthine phosphoribosyltransferase, purine nucleoside phosphorylase, or adenosine deaminase.
    Thompson LF; Willis RC; Stoop JW; Seegmiller JE
    Proc Natl Acad Sci U S A; 1978 Aug; 75(8):3722-6. PubMed ID: 99741
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.